Key points:
·Member Recruitment: The FDA is openly soliciting members for the Tobacco Products Scientific Advisory Committee, covering experts from various medical and scientific fields.
·Nomination Deadline: The deadline for nominations is August 25, 2025, and can be submitted electronically or by mail.
·Term Arrangement: New members will serve for a maximum of four years, starting from February 1, 2026.
·Committee Responsibilities: TPSAC is responsible for reviewing the safety, dependence, and health issues of tobacco products, providing professional advice to the FDA.
According to an FDA announcement on July 30th, the FDA is seeking nominations for voting members to join the Tobacco Products Scientific Advisory Committee (TPSAC) by August 25, 2025. Individuals can self-nominate or be nominated by any interested person or organization.
Specifically, the TPSAC is looking for five vacant members, who should be doctors, dentists, scientists, or healthcare professionals specializing in oncology, pulmonology, cardiology, toxicology, pharmacology, engineering, or other related fields. Among these five vacancies are one for a representative of the general public and one for a federal, state, or local government employee. The selected members will be invited to serve for a maximum of four years, with their term beginning on February 1, 2026, after the current members' terms end.
All nominations should be submitted electronically through the FDA Advisory Nomination Portal, or by email to the committee's oversight and management staff. Nominations received after August 25, 2025 will be considered for future committee vacancies.
The Tobacco Products Scientific Advisory Committee (TPSAC) advises the FDA on matters related to tobacco product regulation, such as applications for modified risk tobacco products submitted by manufacturers. This committee reviews and evaluates the safety, addictiveness, and health issues related to tobacco products, and provides appropriate advice, information, and recommendations to the FDA Commissioner.
We welcome news tips, article submissions, interview requests, or comments on this piece.
Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn
Notice
1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.
2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.
3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.
4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.
Copyright
This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.
For copyright-related inquiries, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.
We welcome any corrections or feedback. Please contact us at: info@2firsts.com
